IVF in Turkey: Procedure, Costs and What to Expect

Turkey has emerged as one of the leading medical tourism destinations for fertility treatment, particularly IVF, because it combines internationally trained reproductive specialists, well-equipped fertility laboratories and cost structures that are 50 to 70 percent lower than those found in the UK, USA or Western Europe.

Many Turkish fertility clinics hold international accreditations and routinely treat patients from across Europe, the Middle East and Central Asia.

The regulatory environment in Turkey permits a range of assisted reproduction techniques including standard IVF, ICSI, blastocyst culture and preimplantation genetic testing in specific clinical contexts. Egg donation IVF is also available in Turkey, which distinguishes it from several European countries where egg donation is legally restricted or involves very long waiting lists.

For patients who have experienced clinic delays or cost barriers at home, Turkey offers an accessible combination of clinical quality, shorter waiting times and substantially reduced out-of-pocket expense. The decision to travel for IVF should still be based on clinical assessment and realistic expectations about success rates rather than cost alone.

An IVF cycle begins with an initial consultation and diagnostic assessment that evaluates the patient's ovarian reserve, uterine anatomy and the partner's sperm parameters. This diagnostic phase can be conducted remotely in part, with hormonal blood tests done locally and results sent to the Turkish clinic before travel.

Once the diagnostic picture is complete and a treatment protocol selected, the stimulation phase begins. Patients self-administer daily hormone injections to stimulate the ovaries to produce multiple follicles over approximately ten to fourteen days. Regular ultrasound monitoring checks follicle growth during this period.

When follicles reach the appropriate size, a trigger injection is given and egg retrieval takes place approximately thirty-six hours later under sedation. Retrieved eggs are fertilised in the laboratory using either conventional IVF or ICSI. Fertilised embryos are cultured to day three or blastocyst stage over the following three to five days.

The strongest viable embryos are then transferred to the uterus in a brief procedure. Remaining quality embryos can be vitrified and stored for future cycles.

The most consistent predictor of IVF success is the patient's age and ovarian reserve. Women under 35 with good ovarian reserve generally achieve the highest live birth rates per cycle. Success rates decline progressively from 35 onwards and particularly after age 40. Clinics that publish success rates should be able to break them down by age group and whether they represent fresh or cumulative outcomes.

Embryo quality is closely linked to stimulation protocol design, laboratory handling and culture conditions. The quality of the embryology laboratory, embryologist experience and incubator technology all influence the percentage of retrieved eggs that reach transferable embryo stage. This is one of the most important yet invisible variables when comparing clinics.

Uterine receptivity affects implantation. Conditions including thin endometrium, polyps, fibroids or hydrosalpinx can reduce implantation success even when high-quality embryos are transferred. Clinics that conduct thorough uterine assessment before transfer rather than proceeding without investigation generally report better outcomes in cases where receptivity might otherwise be compromised.

For a fresh IVF cycle where the patient undergoes stimulation in Turkey, the total stay typically spans twelve to sixteen days. This covers the monitoring appointments during stimulation, egg retrieval, the embryo culture wait and embryo transfer.

Some patients prefer to do stimulation partly in their home country under local clinic coordination and travel to Turkey only for the egg retrieval and embryo transfer phase, which reduces the Turkish stay to approximately five days.

For frozen embryo transfer cycles where embryos from a previous cycle are already stored at the Turkish clinic, the visit is much shorter, typically three to four days covering endometrium preparation monitoring and the transfer procedure.

For egg donation cycles, the recipient travel requirement depends on whether a fresh or frozen donor egg program is used. Frozen donor egg programs generally require a single coordinated visit of four to seven days, which is operationally simpler for international patients than fresh donor cycles that require donor and recipient cycle synchronisation.

The most important clinical checks when evaluating an IVF clinic in Turkey focus on laboratory quality and success rate transparency. A credible clinic should be able to provide age-stratified success rates that distinguish between live birth rates and clinical pregnancy rates, and between fresh and cumulative outcomes over two to three cycles.

Patients should ask about the embryology laboratory's accreditation, the clinic's embryo vitrification survival rate, whether genetic testing is available if clinically indicated and whether the clinic uses time-lapse imaging or other evidence-based embryo selection tools.

Coordination quality is especially important for international patients. A well-organised clinic will manage the remote diagnostic phase, provide clear medication instructions before travel and assign a dedicated coordinator who communicates across time zones throughout the cycle.

Patients should also understand the clinic's policy on cycle cancellation due to poor response and what happens if fewer eggs are retrieved than expected.

NexWell helps patients planning IVF in Turkey by reviewing the clinical assessment from the proposed clinic, checking whether the recommended protocol is appropriate for the patient's diagnostic profile and evaluating whether the clinic's published success data is presented transparently or in a format designed to appear more favourable than the underlying numbers support.

We also check whether the coordination model is realistic for international patients, whether medication logistics and remote monitoring are well managed and whether the cost estimate includes all cycle-specific expenditures or carries a risk of undisclosed additional charges.

For patients considering egg donation, we provide additional review of how the donor matching process works, what health screening donors receive and whether the clinic can explain the legal framework surrounding egg donation for international patients in their home country's context.

Before committing to an IVF clinic in Turkey, patients benefit from written answers to the following:

What are your live birth rates per embryo transfer, broken down by patient age and donor versus own egg cycles?

What diagnostic tests are required before my first cycle and which can be done locally before travel?

Which stimulation protocol are you recommending for my specific hormone profile and why?

What laboratory accreditation does the clinic hold and what is your embryo vitrification survival rate?

What is the cycle cancellation policy if my ovarian response is poor?

What is the total all-inclusive cost of one IVF cycle and what might add cost beyond the initial estimate?

How are medication prescriptions managed for international patients and can they be sent to my home country?

What remote support is available between monitoring appointments during stimulation?

What is the embryo storage policy and fee structure for frozen embryo cycles?